<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940617-1-00093</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;333.403  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Definitions.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> As used in this subpart: (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Antiseptic drug. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In accordance with section 201(o) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 321(o)), ``The representation of a drug, in its labeling, as an antiseptic shall be considered to be a representation that it is a germicide, except in the case of a drug purporting to be, or represented as, an antiseptic for inhibitory use as a wet dressing, ointment, dusting powder, or such other use as involves prolonged contact with the body.'' (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Broad spectrum activity. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  A properly formulated drug product, containing an ingredient included in the monograph, that possesses in vitro activity against the micro-organisms listed in &sect;333.470(a)(1)(ii), as demonstrated by in vitro minimum inhibitory concentration determinations conducted according to methodology established in &sect;333.470(a)(1)(ii). (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Health-care antiseptic. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  An antiseptic containing drug product applied topically to the skin to help prevent infection or to help prevent cross contamination. (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Antiseptic handwash or health-care personnel handwash drug product. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  An antiseptic containing preparation designed for frequent use; it reduces the number of transient micro-organisms on intact skin to an initial baseline level after adequate washing, rinsing, and drying; it is broad spectrum, fast acting and, if possible, persistent. (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Patient preoperative skin preparation drug product. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  A fast acting, broad spectrum, and persistent antiseptic containing preparation that significantly reduces the number of micro-organisms on intact skin. (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Surgical hand scrub drug product. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  An antiseptic containing preparation that significantly reduces the number of micro-organisms on intact skin; it is broad spectrum, fast acting, and persistent.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;333.410  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Antiseptic handwash or health-care personnel handwash active ingredients.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The active ingredient of the product consists of any of the following within the specified concentration established for each ingredient properly formulated to meet the test requirements in &sect;333.470, and the product is labeled according to &sect;&sect;333.450 and 333.455: (a) Alcohol 60 to 95 percent by volume in an aqueous solution denatured according to Bureau of Alcohol, Tobacco and Firearms regulations in 27 CFR part 20; or (b) Povidone-iodine 5 to 10 percent.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;333.412  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Patient preoperative skin preparation active ingredients.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The active ingredient of the product consists of any of the following within the specified concentration established for each ingredient properly formulated to meet the test requirements in &sect;333.470, and the product is labeled according to &sect;&sect;333.450 and 333.460: (a) Alcohol 60 to 95 percent by volume in an aqueous solution denatured according to Bureau of Alcohol, Tobacco and Firearms regulations in 27 CFR part 20; (b) Iodine tincture U.S.P.; (c) Iodine topical solution U.S.P.; (d) Isopropyl alcohol 70 to 91.3 percent by volume in an aqueous solution; and (e) Povidone-iodine 5 to 10 percent.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;333.414  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Surgical hand scrub active ingredients.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The active ingredient of the product consists of any of the following within the specified concentration established for each ingredient properly formulated to meet the test requirements in &sect;333.470, and the product is labeled according to &sect;&sect;333.450 and 333.465: (a) Alcohol 60 to 95 percent by volume in an aqueous solution denatured according to Bureau of Alcohol, Tobacco and Firearms regulations in 27 CFR part 20; or (b) Povidone-iodine 5 to 10 percent.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;333.420  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Permitted combinations of active ingredients.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> [Reserved]  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            